Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors

被引:54
作者
de Pooter, Renee F.
Schmitt, Thomas M.
de la Pompa, Jose Luis
Fujiwara, Yuko
Orkin, Stuart H.
Zuniga-Pflucker, Juan Carlos
机构
[1] Univ Toronto, Sunnybrook & Womens Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada
[2] Univ Autonoma Madrid, Consejo Super Invest Cientificas, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain
[3] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.176.9.5267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The bone marrow and thymus, although both hemopoietic environments, induce very distinct differentiation outcomes. The former supports hemopoietic stem cell self-renewal and multiple hemopoietic lineages, while the latter supports T lymphopoiesis almost exclusively. This distinction suggests that the thymic environment acts to restrict the hemopoietic fates available to thymic immigrants. In this study, we demonstrate that the addition of the Notch ligand Delta-like-1 (DII-1) to an in vitro system that otherwise supports myelopoiesis, greatly reduces the myelopoietic potential of stem cells or uncommitted progenitors. In contrast, committed myeloid progenitors mature regardless of the presence of DII-1. The block in myelopoiesis is the direct result of Notch signaling within the hemopoietic progenitor, and DII-1-induced signals cause a rapid increase in the expression of the zinc finger transcription factor GATA-2. Importantly, in the absence of GATA-2, DII-1-induced signals fail to inhibit commitment to the myeloid fate. Taken together, our results support a role for GATA-2 in allowing DII-1 to restrict non-T cell lineage differentiation outcomes.
引用
收藏
页码:5267 / 5275
页数:9
相关论文
共 76 条
  • [1] Analysis of the mouse CSF-1 gene promoter in a transgenic mouse model
    Abboud, SL
    Bunegin, M
    Ghosh-Choudhury, N
    Woodruff, K
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (07) : 941 - 949
  • [2] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
    Akashi, K
    Traver, D
    Miyamoto, T
    Weissman, IL
    [J]. NATURE, 2000, 404 (6774) : 193 - 197
  • [3] Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells
    Amsen, D
    Blander, JM
    Lee, GR
    Tanigaki, K
    Honjo, T
    Flavell, RA
    [J]. CELL, 2004, 117 (04) : 515 - 526
  • [4] Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO
  • [5] 2-S
  • [6] Anderson MK, 1999, DEVELOPMENT, V126, P3131
  • [7] CSL-independent Notch signalling: a checkpoint in cell fate decisions during development?
    Arias, AM
    Zecchini, V
    Brennan, K
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (05) : 524 - 533
  • [8] Notch signaling: Cell fate control and signal integration in development
    Artavanis-Tsakonas, S
    Rand, MD
    Lake, RJ
    [J]. SCIENCE, 1999, 284 (5415) : 770 - 776
  • [9] Microenvironmental influences on human B-cell development
    Bertrand, FE
    Eckfeldt, CE
    Fink, JR
    Lysholm, AS
    Pribyl, JAR
    Shah, N
    LeBien, TW
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 175 : 175 - 186
  • [10] Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines
    Bigas, A
    Martin, DIK
    Milner, LA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) : 2324 - 2333